Margaret K. Kyle
Names
| first: |
Margaret |
| middle: |
K. |
| last: |
Kyle |
Identifer
Contact
Affiliations
-
Mines Paris
/ Centre d'Économie Industrielle (CERNA)
Research profile
author of:
- Public & Private Spillovers: Location and the Productivity of Pharmaceutical Research (RePEc:adr:anecst:y:2005:i:79-80:p:165-188)
by Jeffrey Furman & Margaret K. Kyle & Alain Cockburn & Rebecca M. Henderson - Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs (RePEc:aea:aecrev:v:107:y:2017:i:5:p:486-90)
by Margaret Kyle & Heidi Williams - Lessons for the United States from Pharmaceutical Regulation Abroad (RePEc:aea:jecper:v:39:y:2025:i:2:p:53-78)
by Margaret K. Kyle - Intellectual Property Protection and the Geography of Trade (RePEc:bla:jindec:v:61:y:2013:i:3:p:733-762)
by Mercedes Delgado & Margaret Kyle & Anita M. McGahan - The role of firm characteristics in pharmaceutical product launches (RePEc:bla:randje:v:37:y:2006:i:3:p:602-618)
by Margaret K. Kyle - Strategic Responses to Parallel Trade (RePEc:bpj:bejeap:v:11:y:2011:i:2:n:2)
by Kyle Margaret - MATLAB/C code for GIG and BNLG common value auction specifications (RePEc:cod:matlab:gigbnlg)
by Michael Gordy & Margaret Kyle - The Effects of Pharmaceutical Innovation on Cancer Mortality (RePEc:cpr:ceprdp:11487)
by Kyle, Margaret & Dubois, Pierre - Strategic Interaction Among Governments in the Provision of a Global Public Good (RePEc:cpr:ceprdp:12419)
by Kyle, Margaret & Ridley, David & Zhang, Su - Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets (RePEc:cpr:ceprdp:12420)
by Kyle, Margaret - Inefficiencies in technology transfer: theory and empirics (RePEc:cpr:ceprdp:8206)
by Kyle, Margaret & Allain, Marie-Laure - Investments in Pharmaceuticals Before and After TRIPS (RePEc:cpr:ceprdp:8371)
by Kyle, Margaret & McGahan, Anita M - Markets for Pharmaceutical Products11The authors thank Tom McGuire for editorial advice and improvements and participants at the Handbook conference for helpful suggestions (RePEc:eee:heachp:2-763)
by Scott Morton, Fiona & Kyle, Margaret - Incentives for pharmaceutical innovation: What’s working, what’s lacking (RePEc:eee:indorg:v:84:y:2022:i:c:s0167718722000261)
by Kyle, Margaret K. - Strategic interaction among governments in the provision of a global public good (RePEc:eee:pubeco:v:156:y:2017:i:c:p:185-199)
by Kyle, Margaret K. & Ridley, David B. & Zhang, Su - Mergers and Alliances in Pharmaceuticals: Effects on Innovation and R&D Productivity (RePEc:elg:eechap:13007_11)
by Henry Grabowski & Margaret Kyle - Objective and self‐report work performance measures: a comparative analysis (RePEc:eme:ijppmp:17410400610671426)
by Glenn Pransky & Stan Finkelstein & Ernst Berndt & Margaret Kyle & Joan Mackell & Dan Tortorice - Does locale affect R&D productivity? the case of pharmaceuticals (RePEc:fip:fedfel:y:2004:i:nov12:n:2004-32)
by Margaret K. Kyle - Did U.S. bank supervisors get tougher during the credit crunch? Did they get easier during the banking boom? Did it matter to bank lending? (RePEc:fip:fedgfe:2000-39)
by Allen N. Berger & Margaret K. Kyle & Joseph M. Scalise - Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs (RePEc:hal:journl:hal-01448505)
by Margaret Kyle & Heidi Williams - Competition Law, Intellectual Property, and the Pharmaceutical Sector (RePEc:hal:journl:hal-01448506)
by Margaret Kyle - Study for European Commission (DG Internal Market, Industry, Entrepreneurship and SMEs) on supplementary patent certificates (RePEc:hal:journl:hal-01448507)
by Margaret Kyle - Competition law, intellectual property, and the pharmaceutical sector (RePEc:hal:journl:hal-01514478)
by Margaret Kyle - Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets (RePEc:hal:journl:hal-01952663)
by Margaret Kyle - Strategic interaction among governments in the provision of a global public good (RePEc:hal:journl:hal-01952672)
by Margaret Kyle & David Ridley & Su Zhang - Estimating the Benefits of Cancer Treatments (RePEc:hal:journl:hal-01952710)
by Pierre Dubois & Margaret Kyle - Strategic interaction among governments in the provision of a global public good (RePEc:hal:journl:hal-01952712)
by Margaret Kyle & David Ridley & Su Zhang - Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs (RePEc:hal:journl:hal-01952720)
by Margaret Kyle & Heidi Williams - The Single Market in Pharmaceuticals (RePEc:hal:journl:hal-02055979)
by Margaret Kyle - Productivity and competitiveness in the euro area: A view from France
[Productivité et compétitivité : où en est la France dans la zone euro ?] (RePEc:hal:journl:hal-02452575)
by Margaret Kyle & Agnès Bénassy-Quéré & Olivier Blanchard & Laurence Boone & Gilberte Cette & Chiara Criscuolo & Anne Epaulard & Jean Sebastien & Xavier Ragot & Philippe Martin & Alexandra Roulet & Davi - The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals (RePEc:hal:journl:hal-02452622)
by Margaret Kyle - The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals (RePEc:hal:journl:hal-03109956)
by Margaret Kyle - Innovation pharmaceutique : comment combler le retard français ? (RePEc:hal:journl:hal-03150073)
by Margaret Kyle & Anne Perrot - Do Patents Work? Evidence from Pharmaceutical Innovation (RePEc:hal:journl:hal-03519736)
by Margaret Kyle - Competition and the Efficiency of Markets for Technology (RePEc:hal:journl:hal-03542108)
by Marie-Laure Allain & Emeric Henry & Margaret Kyle - Incentives for pharmaceutical innovation: What’s working, what’s lacking (RePEc:hal:journl:hal-03935839)
by Margaret Kyle - “Economic Issues in Assessing Potential and Nascent Competition” (RePEc:hal:journl:hal-03935872)
by Andrew Elzinga & Nikhil Gupta & Margaret Kyle & Vivek Mani - Intersection of Intellectual Property and Competition Policy in Recent Cases (RePEc:hal:journl:hal-03935948)
by Margaret Kyle & Vivek Mani & Sinan Corus - COVID-19 and clinical trials (RePEc:hal:journl:hal-03936125)
by Margaret Kyle - The More We Die, The More We Sell? A Simple Test of the Home-Market Effect (RePEc:hal:journl:hal-04094236)
by Arnaud Costinot & Dave Donaldson & Margaret Kyle & Heidi Williams - The economics of new product launches and access to pharmaceutical products in the EU: A perspective on the EC’s proposed reform of the EU pharmaceutical legislation (RePEc:hal:journl:hal-04351643)
by Margaret Kyle & Sinan Corus & Julia Tanndal - Hot tub time machine? What role for Towercast in EU merger control (RePEc:hal:journl:hal-04868687)
by Margaret Kyle & Omar Shah & Vivek Mani - Evolving Brand-Name And Generic Drug Competition May Warrant A Revision Of The Hatch-Waxman Act (RePEc:hal:journl:halshs-00738443)
by G. Grabowski Henry & Margaret Kyle & Richard Mortimer & Genia Long & Noam Kirson - Evolution of Market Exclusivity, Paragraph IV Challenges and Generic Penetration (RePEc:hal:journl:halshs-00738629)
by Henry.G Grabowski & Margaret Kyle & Richard Mortimer & Genia Long & Noam Kirson - Assessing the population health impact of market interventions to improve access to antiretroviral treatment (RePEc:hal:journl:halshs-00739081)
by Margaret Kyle & Till Barnighausen & Joshua Salomon & Brenda Waning - Inefficiencies in the sale of ideas: theory and empirics (RePEc:hal:spmain:hal-00639128)
by Marie-Laure Allain & Emeric Henry & Margaret Kyle - Productivity and competitiveness in the euro area: A view from France
[Productivité et compétitivité : où en est la France dans la zone euro ?] (RePEc:hal:spmain:hal-02452575)
by Margaret Kyle & Agnès Bénassy-Quéré & Olivier Blanchard & Laurence Boone & Gilberte Cette & Chiara Criscuolo & Anne Epaulard & Jean Sebastien & Xavier Ragot & Philippe Martin & Alexandra Roulet & Davi - Inefficiencies in technology transfer: theory and empirics (RePEc:hal:spmain:hal-03473787)
by Marie-Laure Allain & Emeric Henry & Margaret Kyle - Competition and the Efficiency of Markets for Technology (RePEc:hal:spmain:hal-03542108)
by Marie-Laure Allain & Emeric Henry & Margaret Kyle - Inefficiencies in the sale of ideas: theory and empirics (RePEc:hal:wpaper:hal-00639128)
by Marie-Laure Allain & Emeric Henry & Margaret Kyle - The More We Die, The More We Sell? A Simple Test of the Home-Market Effect (RePEc:hal:wpaper:hal-01448519)
by A. Costinot, & D. Donaldson, & Margaret Kyle & H. Williams, - Government Free-riding in Research Funding (RePEc:hal:wpaper:hal-01448520)
by Margaret Kyle & D. Ridley, & S. Zhang, - Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets (RePEc:hal:wpaper:hal-01448521)
by Margaret Kyle - Estimating the Benefits of Innovation (RePEc:hal:wpaper:hal-01448523)
by Margaret Kyle & P. Dubois - Intellectual Property Rights and Access to Innovation: Evidence from TRIPS (RePEc:hal:wpaper:hal-01448524)
by Margaret Kyle - Intellectual property rights and access to innovation: evidence from TRIPS (RePEc:hal:wpaper:hal-01952690)
by Margaret Kyle & Qian Yi - Korean pharmaceutical industry policy: lessons for Korea (RePEc:hal:wpaper:hal-01952703)
by Daejung Kim & Alistair Mcguire & Margaret Kyle - Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets (RePEc:hal:wpaper:hal-01952727)
by Margaret Kyle - Inefficiencies in technology transfer: theory and empirics (RePEc:hal:wpaper:hal-03473787)
by Marie-Laure Allain & Emeric Henry & Margaret Kyle - Competition and the Efficiency of Markets for Technology (RePEc:ide:wpaper:27400)
by Allain, Marie-Laure & Henry, Emeric & Kyle, Margaret - Competition and the Efficiency of Markets for Technology (RePEc:inm:ormnsc:v:62:y:2016:i:4:p:1000-1019)
by Marie-Laure Allain & Emeric Henry & Margaret Kyle - Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets (RePEc:kap:revind:v:53:y:2018:i:1:d:10.1007_s11151-018-9639-7)
by Margaret K. Kyle - The Single Market in Pharmaceuticals (RePEc:kap:revind:v:55:y:2019:i:1:d:10.1007_s11151-019-09694-6)
by Margaret K. Kyle - Did US Bank Supervisors Get Tougher during the Credit Crunch? Did They Get Easier during the Banking Boom? Did It Matter to Bank Lending? (RePEc:nbr:nberch:10764)
by Allen N. Berger & Margaret K. Kyle & Joseph M. Scalise - Public and Private Spillovers: Location and the Productivity of Pharmaceutical Research (RePEc:nbr:nberch:12232)
by Jeffrey L. Furman & Margaret K. Kyle & Iain Cockburn & Rebecca M. Henderson - The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals (RePEc:nbr:nberch:14260)
by Margaret K. Kyle - The Long Shadow of Patent Expiration. Generic Entry and Rx-to-OTC Switches (RePEc:nbr:nberch:9737)
by Ernst R. Berndt & Margaret Kyle & Davina Ling - Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research (RePEc:nbr:nberwo:12509)
by Jeffrey L. Furman & Margaret K. Kyle & Iain M. Cockburn & Rebecca Henderson - Strategic Responses to Parallel Trade (RePEc:nbr:nberwo:12968)
by Margaret K. Kyle - Investments in Pharmaceuticals Before and After TRIPS (RePEc:nbr:nberwo:15468)
by Margaret Kyle & Anita McGahan - Intellectual Property Rights and Access to Innovation: Evidence from TRIPS (RePEc:nbr:nberwo:20799)
by Margaret Kyle & Yi Qian - The More We Die, The More We Sell? A Simple Test of the Home-Market Effect (RePEc:nbr:nberwo:22538)
by Arnaud Costinot & Dave Donaldson & Margaret Kyle & Heidi Williams - Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs (RePEc:nbr:nberwo:23068)
by Margaret Kyle & Heidi L. Williams - Did U.S. Bank Supervisors Get Tougher During the Credit Crunch? Did They Get Easier During the Banking Boom? Did It Matter to Bank Lending? (RePEc:nbr:nberwo:7689)
by Allen N. Berger & Margaret K. Kyle & Joseph M. Scalise - The More We Die, The More We Sell? A Simple Test of the Home-Market Effect (RePEc:oup:qjecon:v:134:y:2019:i:2:p:843-894.)
by Arnaud Costinot & Dave Donaldson & Margaret Kyle & Heidi Williams - Unknown item RePEc:spo:wpmain:info:hdl:2441/eu4vqp9ompqllr09iatrn4log (paper)
- Pharmaceutical Price Controls and Entry Strategies (RePEc:tpr:restat:v:89:y:2007:i:1:p:88-99)
by Margaret K. Kyle - Investments in Pharmaceuticals Before and After TRIPS (RePEc:tpr:restat:v:94:y:2012:i:4:p:1157-1172)
by Margaret K. Kyle & Anita M. McGahan - Competition and the Efficiency of Markets for Technology (RePEc:tse:wpaper:27399)
by Allain, Marie-Laure & Henry, Emeric & Kyle, Margaret - The Effects of Pharmaceutical Innovation on Cancer Mortality Rates (RePEc:tse:wpaper:30703)
by Dubois, Pierre & Kyle, Margaret - The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals (RePEc:ucp:ipolec:doi:10.1086/705640)
by Margaret K. Kyle - Deregulating Direct-to-Consumer Marketing of Prescription Drugs: Effects on Prescription and Over-the-Counter Product Sales (RePEc:ucp:jlawec:doi:10.1086/368004)
by Davina C. Ling & Ernst R. Berndt & Margaret K. Kyle - Generic competition and market exclusivity periods in pharmaceuticals (RePEc:wly:mgtdec:v:28:y:2007:i:4-5:p:491-502)
by Henry G. Grabowski & Margaret Kyle